Hello Nova Scotia CFA members, A Patient Empowerment Meeting is coming your way! Put October 14th in your calendar and fill out the registration form to join us for an empowering day! Below is the information and also please click here to register!
Please keep reading for details! Registration: Click here
Full Press release link Idorsia Pharmaceuticals (www.idorsia.com), a Swiss biotech company, is developing lucerastat, a new oral therapy for patients with Fabry Disease. The Phase 3 clinical study MODIFY has just enrolled its first patients and will investigate the use of lucerastat monotherapy for the treatment of adult patients with Fabry disease, irrespective of their […]
We are committed to improving the lives of those who live with and are affected by Fabry disease in Canada.
Subscribe error, please review your email address.Close
You're now subscribed, thank you!Close
There was a problem with your submission. Please check the field(s) with red label below.Close
Your message has been sent. We'll get back to you soon!Close